IASLC 18th WCLC Special Session Provides Overview of Updated Guidelines for Molecular Testing
Posted: December 2017 Experts in molecular testing discussed various issues on this topic in October at the IASLC 18th WCLC. Neal Lindeman, MD, led off the session with an overview […] Read more
By Christian Rolfo, MD, PhD, MBAh, and Philip C. Mack, PhD Posted: December 2017 In just the past decade, tremendous advancements in the treatment of metastatic non-small cell lung cancer […] Read more
By Cynthia L. Kryder, MS and Lori L. Alexander, MTPW, ELS, MWC Posted: December 2017 An oral abstract session at the IASLC World Conference on Lung Cancer (WCLC) 2017 drew […] Read more
By Luis E. Raez, MD Posted: December 2017 Under the sponsorship of the IASLC, the Peruvian Association for Bronchology and Interventional Pulmonology (APBNI) organized a seminar on bronchoscopy ultrasound (EBUS) […] Read more
By Emily Stone, MBBS, MMed, FRACP, and James Jett, MD Posted: December 2017 Cannabis, a generic term for various products derived from the plant cannabis sativa, has a long history […] Read more
Posted: December 2017 Patients with completely resected early-stage non-small cell lung cancer (NSCLC) have approximately a 50% chance of experiencing disease recurrence following standard treatment. In 2014, the NCI initiated […] Read more
By Jyoti Patel, MD, and Heather A. Wakelee, MD Posted: December 2017 The IASLC 2017 Chicago Multidisciplinary Symposium in Thoracic Oncology was held September 14-16, 2017 and brought together nearly […] Read more
Posted: December 2017 The Information Exchange and Data Transformation (INFORMED) initiative was launched by the U.S. Food and Drug Administration (FDA) and the Innovation, Design, Entrepreneurship and Action (IDEA) Lab […] Read more
Patients with EGFR Mutation Should Postpone Brain Radiation for CNS Metastases: Pro and Con
By Pranshu Mohindra, MD, MBBS, DABR®, Lecia Sequist, MD, and Laurie E. Gaspar, MD, MBA Posted: December 2017 Since the initial approval of erlotinib, an oral tyrosine kinase inhibitor (TKI), […] Read more
By Fabrice Barlesi, MD, PhD Posted: December 2017 Since the advent of adjuvant platinumbased chemotherapy as the standard of care, little progress has been achieved in significantly improving the cure […] Read more